Psoriasis Induced by Trastuzumab (Herceptin®)

Trastuzumab (Herceptin), a humanized monoclonal antibody, is a cancer drug developed to target the human epidermal receptor (HER) 2, which is overexpressed in some cancer cells. Cutaneous side effects, such as folliculitis, xerosis, and alopecia have not been reported with therapies targeting HER2,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kim, Dae Hun, Jeong, Nam Ji, Im, Myung, Lee, Young, Seo, Young Joon, Lee, Jeung Hoon
Formato: Artigo
Lenguaje:Inglês
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2013
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3662920/
https://ncbi.nlm.nih.gov/pubmed/23717018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2013.25.2.229
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares